Transient ischaemic attack 999 emergency referral
- Conditions
- Transient ischaemic attack (TIA)Circulatory System
- Registration Number
- ISRCTN85516498
- Lead Sponsor
- Welsh Ambulance Services NHS Trust
- Brief Summary
2017 Other publications in https://pubmed.ncbi.nlm.nih.gov/28196949/ scoping review (added 10/12/2020) Abstract results in https://emj.bmj.com/content/33/9/e13.1 (added 14/11/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 156
Patients will be eligible for the study if they are:
1. Attended by a trial paramedic during the recruitment period
2. Coded as low-risk suspected TIA by the attending paramedic using the standard tool
3. Attended in the catchment area of the two hospitals taking part in the trial
All paramedics working in within the study area are eligible
There are no exclusion criteria for paramedics.
Patient exclusion criteria:
1. Unable to give informed consent (lacks capacity)
2. Apparent or known cognitive impairment (such as a diagnosis of dementia), due to the
potential for inaccuracies in the reporting of symptoms
3. Patients with crescendo TIAs (i.e. patient has had similar symptoms within the last week)
4. Patients with ongoing symptoms (i.e. cannot definitely be classified as a TIA)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Time to subsequent emergency contact (999 call or ED attendance) or death<br> 2. Time to specialist assessment by a stroke consultant or TIA specialist nurse<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Outcome of contact: whether patient is taken to hospital or left at home and referred or left at home but not referred, together with time from onset to additional therapy; and attendance at TIA clinic (who and when)<br> 2. Health care utilisation in one month and three months following contact<br> 3. Patient-reported outcomes: satisfaction with care received (Quality of Care Monitor); health status (SF-12) at one month and three months<br> 4. Costs of implementation, and costs of care and consequences per patient<br> 5. Appropriateness of clinical management<br>